Action required: Please refresh your browser
We have recently implemented some changes that require a hard refresh of your browser: Please hold down the CTRL-key and press the F5 key.
After a successful hard refresh, this message should not appear anymore.
More details about this topic are available here »
ObsEva SA to present at the Jefferies Virtual Healthcare Conference June 3rd, 2020 | ||
By: GlobeNewswire - 29 May 2020 | Back to overview list |
|
Geneva, Switzerland and Boston, MA – May 29, 2020 – ObsEva SA (NASDAQ: OBSV), a clinical-stage biopharmaceutical company developing and commercializing novel therapies to improve women’s reproductive health, today announced that CEO Ernest Loumaye will present an update on the Company and its pipeline at the Jefferies Virtual Healthcare Conference taking place June 2-4, 2020. Mr. Loumaye’s presentation will take place on Wednesday June 3, 2020 at 8:00 a.m. Eastern Time (ET). A live presentation link will be available under “Events Calendar” in the investors section of ObsEva’s website at www.ObsEva.com About ObsEva ObsEva is a biopharmaceutical company developing and commercializing novel therapies to improve women’s reproductive health and pregnancy. Through strategic in-licensing and disciplined drug development, ObsEva has established a late-stage clinical pipeline with development programs focused on treating endometriosis, uterine fibroids, preterm labor, and improving ET outcomes following IVF. ObsEva is listed on the Nasdaq Global Select Market and is trading under the ticker symbol "OBSV" and on the SIX Swiss Exchange where it is trading under the ticker symbol “OBSN”. For more information, please visit www.ObsEva.com. For further information, please contact: CEO Office contact Investor Contact +1 857 972 9347 Office
Attachment |
||
|
||
Copyright 2020 GlobeNewswire | Back to overview list |